Emphasis on Route of Administration (Oral and Parenteral); Drug Class (Disease-modifying Anti-rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Uric Acid Drugs, and Others), Sales Channel (Prescription-based Drugs and Over-the-counter Drugs); and Region/Country
Rheumatoid Arthritis Market Size & ForecastThe Rheumatoid Arthritis market was valued at approximately USD 27 Billion in 2023 and is expected to grow at a strong CAGR of around 5% during the forecast period (2024-2032) owing to the rising cases of RA.
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily affects the joints, causing inflammation, pain, and potential joint damage. Unlike osteoarthritis, which results from wear and tear, RA occurs when the immune system mistakenly attacks the synovium—the lining of the membranes that surround the joints. This leads to inflammation that can eventually result in bone erosion and joint deformity. Increasing cases of Rheumatoid arthritis is one of the major drivers for the market. For instance, as per the data of census.gov, RA affects about 1% of the global population, with a higher prevalence in women than men. The disease can occur at any age, but it most commonly begins between the ages of 30 and 60.
This section discusses the key market trends that are influencing the various segments of the Rheumatoid Arthritis Market as identified by our team of research experts.
Biologic drugs have revolutionized RA treatment by targeting specific components of the immune system. These include tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and B-cell inhibitors. With the patent expiration of many biologics, biosimilar drugs—highly similar, less expensive versions of biologics—are becoming more prevalent, improving accessibility and reducing treatment costs.
The Rheumatoid Arthritis market in North America has experienced significant growth in recent years, driven by various factors. North America, particularly the U.S., represents one of the largest markets for Rheumatoid Arthritis globally. One of the primary drivers of the Rheumatoid Arthritis market in North America is the high demand for advanced therapeutics, increasing cases of rheumatoid arthritis, and the rising elderly population. For instance, as of 2022, 16.9% of the U.S. population is aged 65 or older, and this percentage is expected to grow as the Baby Boomer generation ages according to the data of Centers for Disease Control and Prevention (CDC). This demographic shift contributes to the rising prevalence of age-related conditions, including RA. Further, North America has a well-established regulatory framework that ensures the safety and efficacy of therapeutics.
The Rheumatoid Arthritis market is competitive, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are UCB S.A., F. HOFFMANN-LA ROCHE LTD, Pfizer Inc, ABBVIE INC., Novartis AG, Eli Lilly and Company, Teva Pharmaceuticals, Inc., BRISTOL-MYERS SQUIBB COMPANY, Merck & Co., Inc., and JOHNSON & JOHNSON.
The global Rheumatoid Arthritis market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Executive Summary
4. Market Dynamics
5. Pricing Analysis
6. Global Rheumatoid Arthritis Market Revenue (usd Bn), 2022-2032f
7. Market Segment By Route Of Administration
8. Market Segment By Drug Class
9. Market Segment By Sales Channel
10. Market Insights By Region
11. Value Chain Analysis
12. Competitive Landscape
13. Company Profiled
14. Acronyms & Assumption
15. Annexure
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Rheumatoid Arthritis market were the three major steps undertaken to create and analyze the adoption of Rheumatoid Arthritis in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Rheumatoid Arthritis market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Rheumatoid Arthritis market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Rheumatoid Arthritis market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as Route of administration, Drug Class, Sales Channel and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Rheumatoid Arthritis market. Further, we conducted factor analysis using dependent and independent variables such as Route of administration, Drug Class, Sales Channel and regions of the Rheumatoid Arthritis market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Rheumatoid Arthritis market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Rheumatoid Arthritis market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Rheumatoid Arthritis market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the Route of administration, Drug Class, Sales Channel and regions in the global Rheumatoid Arthritis market.
The current & future market trends of the global Rheumatoid Arthritis market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the Rheumatoid Arthritis market's current market size and growth potential?
Q2: What are the driving factors for the growth of the Rheumatoid Arthritis market?
Q3: Which segment has the largest share of the Rheumatoid Arthritis market by Route of Administration?
Q4: What are the emerging technologies and trends in the Rheumatoid Arthritis market?
Q5: Which region will dominate the Rheumatoid Arthritis market?
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
